Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Travoprost BID vs TRAVATAN in Glaucoma or Ocular Hypertension
NCT00637130Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Oct 2007
- Primary completion
- Jan 2008
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of travoprost in Open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Oct 2007; status: completed.
02
Drugs
travoprost
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00637130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637130.